TrialThe Lancet. Respiratory medicine2021

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.

Andre C Kalil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.